LIPODYSTROPHY FREQUENCY ACCORDING TO INSULIN TREATMENT REGIMEN IN TYPE 2 DIABETIC PATIENTS: IS INSULIN INJECTION FREQUENCY MATTERS IN ANALOG INSULIN ERA?

Creative Commons License

Gunhan H., Elbasan O., Imre E., Yavuz D. G.

ACTA ENDOCRINOLOGICA-BUCHAREST, cilt.18, sa.2, ss.202-208, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.4183/aeb.2022.202
  • Dergi Adı: ACTA ENDOCRINOLOGICA-BUCHAREST
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE
  • Sayfa Sayıları: ss.202-208
  • Anahtar Kelimeler: Diabetes Mellitus Type 2, insulin, lipodystrophy, lipohypertrophy, lipoatrophy, YOUNG-PATIENTS, RISK-FACTORS, LIPOHYPERTROPHY, LIPOATROPHY, PREVALENCE, SITES
  • Marmara Üniversitesi Adresli: Evet

Özet

Objectives. We aimed to determine lipodystrophy frequency according to insulin treatment regimen and insulin injection frequency in type 2 diabetic patients.